HealthEquity HQY Ratios & Valuation
| FY'26 | FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 69.5%+4.7pp | 64.8%+2.5pp | 62.3%+5.2pp | 57.1%+0.9pp | |
| Operating margin | 24.6%+11.0pp | 13.5%+1.8pp | 11.8%+10.7pp | 1.1%+4.3pp | |
| Net margin | 16.4%+8.3pp | 8.1%+2.5pp | 5.6%+8.6pp | -3%+2.8pp | |
| Returns | |||||
| Return on equity | 10.2%+5.5pp | 4.7%+1.8pp | 2.8%+4.2pp | -1.4%+1.3pp | |
| Return on invested capital | 8.7%+3.8pp | 4.9%+1.6pp | 3.4%+3.0pp | 0.3%+1.4pp | |
| Efficiency | |||||
| Asset turnover | 0.4×0.0× | 0.4×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Liquidity | |||||
| Current ratio | 3.3×+0.2× | 3.1×-1.7× | 4.8×+1.8× | 2.9×+0.6× | |
| Leverage | |||||
| Debt-to-equity | 0.5×0.0× | 0.5×+0.1× | 0.5×-0.1× | 0.5×0.0× | |
| Net debt / EBITDA | 1.4×-1.1× | 2.5×+0.5× | 2×-2.4× | 4.3×-2.6× | |
| Per Share | |||||
| Book value per share | $24.09+1.2% | $23.81+1.7% | $23.40+4.2% | $22.45+0.7% | |
| Valuation | |||||
| Market capitalization | $7.32B-23.5% | $9.57B+47.3% | $6.5B+26.2% | $5.15B+15.3% | |
| Price / earnings | 34×-64.9× | 99×-17.7× | 116.6×— | —— | |
| Price / sales | 5.6×-2.4× | 8×+1.5× | 6.5×+0.5× | 6×+0.1× | |
| Price / book | 3.5×-1.1× | 4.5×+1.3× | 3.2×+0.5× | 2.7×+0.3× | |
| EV / EBITDA | 16.8×-15.2× | 32×+6.0× | 26×-8.6× | 34.6×-11.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are HealthEquity's profit margins?
- HealthEquity (HQY) runs a 70.7% gross margin and a 25.6% operating margin, with a 17.3% net margin.
- Where do HealthEquity's ratios come from?
- Every ratio is computed from HealthEquity's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
